OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of N-substituted sulfamoylbenzamide derivatives as novel inhibitors of STAT3 signaling pathway based on Niclosamide
Xuebao Wang, Kaiqi Wu, Longcheng Fang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 218, pp. 113362-113362
Closed Access | Times Cited: 14
Xuebao Wang, Kaiqi Wu, Longcheng Fang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 218, pp. 113362-113362
Closed Access | Times Cited: 14
Showing 14 citing articles:
Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation
Jinyun Dong, Xiangdong Cheng, Weidong Zhang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 13, pp. 8884-8915
Closed Access | Times Cited: 144
Jinyun Dong, Xiangdong Cheng, Weidong Zhang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 13, pp. 8884-8915
Closed Access | Times Cited: 144
Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation
Yichao Wan, Guoqing Fang, Hongjuan Chen, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113837-113837
Closed Access | Times Cited: 142
Yichao Wan, Guoqing Fang, Hongjuan Chen, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113837-113837
Closed Access | Times Cited: 142
STAT3-mediated osteogenesis and osteoclastogenesis in osteoporosis
Xiaoli Hou, Faming Tian
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 43
Xiaoli Hou, Faming Tian
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 43
Targeting JAK2/STAT3 for the treatment of cancer: A review on recent advancements in molecular development using structural analysis and SAR investigations
Rupali Kohal, Priya Bisht, Ghanshyam Das Gupta, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107095-107095
Closed Access | Times Cited: 14
Rupali Kohal, Priya Bisht, Ghanshyam Das Gupta, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107095-107095
Closed Access | Times Cited: 14
Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticancer and antiinflammatory agents
Xuemei Xu, Zhaojingtao Zhu, Siyu Chen, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 8
Xuemei Xu, Zhaojingtao Zhu, Siyu Chen, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 8
Pharmacological Advances and Therapeutic Applications of Niclosamide in Cancer and Other Diseases
Umm e Laila, Z Zhao, Dongsheng Xu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117527-117527
Open Access
Umm e Laila, Z Zhao, Dongsheng Xu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117527-117527
Open Access
Discovery of STAT3 Inhibitors: Recent Advances and Future Perspectives
Jiatao Song, Jiawei Wang, Sheng Tian, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 16, pp. 1824-1847
Closed Access | Times Cited: 17
Jiatao Song, Jiawei Wang, Sheng Tian, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 16, pp. 1824-1847
Closed Access | Times Cited: 17
Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug
Junyi Ren, Bo Wang, Qifeng Wu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113789-113789
Open Access | Times Cited: 15
Junyi Ren, Bo Wang, Qifeng Wu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113789-113789
Open Access | Times Cited: 15
Novel insights into STAT3 in renal diseases
Ju-tao Yu, Shuai Fan, Xiangyu Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115166-115166
Open Access | Times Cited: 8
Ju-tao Yu, Shuai Fan, Xiangyu Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115166-115166
Open Access | Times Cited: 8
Role of Nrf2, STAT3, and Src as Molecular Targets for Cancer Chemoprevention
Haseeb Ahsan, Salman Ul Islam, Muhammad Bilal Ahmed, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1775-1775
Open Access | Times Cited: 9
Haseeb Ahsan, Salman Ul Islam, Muhammad Bilal Ahmed, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1775-1775
Open Access | Times Cited: 9
Novel inhibitors of the STAT3 signaling pathway: an updated patent review (2014-present)
Rui Wang, Xinyu Cao, Guo‐Qiang Lin, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 6, pp. 667-688
Closed Access | Times Cited: 4
Rui Wang, Xinyu Cao, Guo‐Qiang Lin, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 6, pp. 667-688
Closed Access | Times Cited: 4
Structure-activity relationship studies on O-alkylamino-tethered salicylamide derivatives with various amino acid linkers as potent anticancer agents
Jimin Xu, Hye-Jin Kim, Jiabin Dong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114229-114229
Open Access | Times Cited: 1
Jimin Xu, Hye-Jin Kim, Jiabin Dong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114229-114229
Open Access | Times Cited: 1
(+)-Isocryptotanshinone derivatives and its simplified analogs as STAT3 signaling pathway inhibitors
Xiang Shi, Ting Ting Du, Zhihui Zhang, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 106015-106015
Closed Access
Xiang Shi, Ting Ting Du, Zhihui Zhang, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 106015-106015
Closed Access
Current trends in anticancer drug prototype in vitro pharmacology: bibliometric analysis 2019–2021
PV Ershov, А. С. Макарова
Medicine of Extreme Situations (2021), Iss. 2021(3)
Open Access
PV Ershov, А. С. Макарова
Medicine of Extreme Situations (2021), Iss. 2021(3)
Open Access
